metformin has been researched along with Pharyngeal Neoplasms in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Pharyngeal Neoplasms: Tumors or cancer of the PHARYNX.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Qualitative synthesis also suggests an apparently dose-response relationship and increased benefit when administered alone." | 2.58 | Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review. ( Estrugo Devesa, A; Jané-Salas, E; López-López, J; Saka Herrán, C, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saka Herrán, C | 1 |
| Jané-Salas, E | 1 |
| Estrugo Devesa, A | 1 |
| López-López, J | 1 |
1 review available for metformin and Pharyngeal Neoplasms
| Article | Year |
|---|---|
Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Case-Control Studies; Cohort Studi | 2018 |